Laboratory testing services
Ended Awarded Last action
- Contract number
- HHSN26100004
- Awardee
-
Genedx, LLC UEI H3J4SCC8F671 Part of Opko Health, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,775
Award facts
- Opportunity
-
- N02CP5261224 Solicitation number
- CLIA-certified clinical genetic testing for TP53 Award Notice · Posted Jun 23, 2015
- Contract value 100% obligated
- $5,775.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- MONTGOMRY VLG, MD 20877, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,100 | |
| Original award | $7,875 |
About this award
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides laboratory testing services, including genetic testing and diagnostic services, to support research and clinical programs at the NIH. The contract has a ceiling value of $5,775 and a period of performance through May 22, 2023. The contract was awarded on December 15, 2017 and does not have a set-aside designation, indicating it was competed on the open market. Genedx, a provider of comprehensive genetic testing services, has a long-standing relationship with the NIH, supporting various institutes and research initiatives through firm fixed-price purchase orders. The company's expertise in areas such as mutation analysis, exome and genome sequencing, and mitochondrial testing directly contributes to the NIH's clinical research and patient care missions.
Quick answers
Who was awarded contract HHSN26100004?
HHSN26100004 was awarded to Genedx, LLC by National Cancer Institute (National Institutes of Health) on December 15, 2017.
How much is contract HHSN26100004 worth?
The government has obligated $5,775 on HHSN26100004.
Is contract HHSN26100004 an order under another contract?
Yes. HHSN26100004 is a delivery order under HHSN261201500016I, an indefinite delivery contract.
Was contract HHSN26100004 competed?
The extent of competition for HHSN26100004 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award